Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: luis a. garcia who wrote (938)	3/5/1998 4:59:00 PM
From: Henry Volquardsen	Read Replies (1) \| Respond to of 1115

Luis, I may have come down a bit hard on the current board as a reaction to some of the people on the Yahoo thread who were praising the board as saviors and castigating HealthMed and Katz. Frankly I think there is enough blame to go around for all. katz did indeed appoint these guys and his tenure has been marked by some bizarre behavior. I would much prefer him to stick to the lab. But I also find it hard to praise the board when they made absolutely no effort to communicate anything to the shareholders regarding Healthmed one way or the other. I also believe they responded very slowly. Yes they need time to become familiar with the issues but close to two months before they show any signs of getting started is a bit much. HealthMed's behaviour has also been to secretive for my taste. I remain very positive about the science of Lidakol. But the more I learn about the company the lest excited I am about the businessmen associated with this, and that includes both Katz and the board. I am not sure whether I would invest if I learned the business side of Lidak before the science. I also strongly favor companies where management has a significant stake in the equity so that their interests are aligned with ours. It does bother me that I own more stock than any board member other than Katz. Henry